Our UK Authorised Representative (UKAR) services support PPE manufacturers in achieving compliance with UK regulations. Patient Guard acts as your UK Responsible Person, ensuring safe and compliant access to the Great Britain market.
PPE manufacturers based outside Great Britain (UK) must appoint a UK Authorised Representative (UKAR) to legally place products on the GB market under the Personal Protective Equipment Regulations 2016 (as amended).
A UK Authorised Representative acts as your legal presence within the UK, ensuring compliance with regulatory requirements, including technical documentation, conformity assessment support, and post-market obligations.
Patient Guard acts as your UK PPE regulatory consultancy, ensuring full compliance with UK PPE regulations and smooth access to the GB market.
Without a UK-based representative, non-UK manufacturers cannot legally place PPE on the GB market or meet UKCA regulatory requirements.
Patient Guard provides expert UK Authorised Representative services for PPE manufacturers worldwide. We support technical file reviews, UKCA compliance, labelling verification, and ongoing regulatory obligations.
Whether launching a new product or transferring from an existing UKAR, we ensure a smooth and compliant route to UK market access.
Under the Personal Protective Equipment Regulations 2016 (as amended), a UK Authorised Representative is responsible for ensuring that PPE products comply with regulatory requirements, including:
We assess your PPE products and regulatory requirements.
We review your technical documentation, risk assessments, and conformity data.
Formal appointment via mandate agreement
We confirm readiness for UKCA marking and market placement.
Support with regulatory updates, vigilance, and authority communication.
We support a wide range of PPE products, including:
Per Year
Ensure your smooth entry into the UK PPE market with an UKAR you can trust
We assess your PPE products and review technical documentation for compliance.
Formal designation as your UK Authorised Representative and confirmation of UKCA readiness.
Product ready for GB market placement with continuous regulatory and vigilance support.
Time lines can be as little as 2 business day for single product review and registration, from the day we receive the files from you. This is dependent on all of the information being correct and no corrections needed.
A UK Authorised Representative (UKAR) acts as the mandatory legal representative for non-UK PPE manufacturers placing products on the Great Britain market. They ensure compliance with UK regulations, maintain technical documentation access, and support post-market surveillance.
Yes, all manufacturers based outside the UK must appoint a UK Authorised Representative to place PPE on the GB market. The UKAR must be established in the UK and assumes responsibility for regulatory compliance.
Yes, a PPE manufacturer can change their UK Authorised Representative at any time. This involves terminating the existing agreement, appointing a new UKAR, updating documentation and labelling, and ensuring continuity of compliance.
Patient Guard charges an annual fee, covering multiple PPE products placed on the GB market.
If all required documentation is available and compliant, the process can take as little as 2–5 business days. Timelines depend on the number of products and complexity of documentation.
Click on the links below to discover more:
Medical devices exist to improve health outcomes, but every device carries potential risk. Managing those risks in a structured, documented, and defensible way is essential for regulatory approval and patient safety.
Clinical evidence is central to demonstrating the safety and performance of medical devices in the European Union.
Medical device labelling is more than a packaging exercise. It is a regulatory requirement that communicates essential information about a device’s identity, safety, and intended use.
Regulatory approval is not the end of scrutiny, it is the beginning of structured data collection.
If you are implementing a medical device QMS, preparing for certification, or recovering from audit findings, understanding ISO 13485:2016 requirements is non-negotiable.
2026 represents a significant milestone for the amended IVDR transitional provisions framework.
Speak to one of our regulatory and compliance experts to arrange an obligation-free call. Our experienced team is ready to help you get your medical device to market.
UK Office
For help with the checklist or other aspects of your compliance journey, please reach out to us at Patient Guard and our experts would be happy to help.
UK Office
Thank you! The checklist is now ready to download.
For help with the checklist or other aspects of your compliance journey, please reach out to us at Patient Guard and our experts would be happy to help.
UK Office
